Chemistry:Niflumic acid
From HandWiki
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Drug used in treatment of joint and muscular pain
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 2.5 hr[1] |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
Chemical and physical data | |
Formula | C13H9F3N2O2 |
Molar mass | 282.222 g·mol−1 |
3D model (JSmol) | |
Melting point | 204 °C (399 °F) |
| |
| |
NY (what is this?) (verify) |
Niflumic acid is a drug used for joint and muscular pain. It is categorized as an inhibitor of cyclooxygenase-2. In experimental biology, it has been employed to inhibit chloride channels.[2] It has also been reported to act on GABA-A[3] and NMDA channels[4] and to block T-type calcium channels.[5]
References
- ↑ "Half life". Drug Bank. http://www.drugbank.ca/drugs/DB04552.
- ↑ "Use of niflumic acid to determine the nature of the asymmetry of the human erythrocyte anion exchange system". The Journal of General Physiology 83 (5): 703–25. May 1984. doi:10.1085/jgp.83.5.703. PMID 6736917.
- ↑ "Receptor subtype-dependent positive and negative modulation of GABA(A) receptor function by niflumic acid, a nonsteroidal anti-inflammatory drug". Molecular Pharmacology 64 (3): 753–63. September 2003. doi:10.1124/mol.64.3.753. PMID 12920213.
- ↑ "Chloride transport blockers prevent N-methyl-D-aspartate receptor-channel complex activation". Molecular Pharmacology 41 (2): 217–22. February 1992. PMID 1371581.
- ↑ "Niflumic acid blocks native and recombinant T-type channels". Journal of Cellular Physiology 227 (6): 2542–55. June 2012. doi:10.1002/jcp.22992. PMID 21898399.
Pyrazolones / Pyrazolidines | |
---|---|
Salicylates | |
Acetic acid derivatives and related substances | |
Oxicams | |
Propionic acid derivatives (profens) |
|
N-Arylanthranilic acids (fenamates) | |
Coxibs | |
Other | |
Items listed in bold indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications. |
Anti-inflammatory preparations, non-steroids |
| ||||||
---|---|---|---|---|---|---|---|
Capsaicin derivatives | |||||||
Other |
0.00 (0 votes)
|